$4.13
-0.27-6.02%
Últ. Act.: Oct 30, 9:15 AM
CollPlant Biotechnologies (CLGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-24.00 | $-19.00 | $25.00 |
| Actual | $-1.69 | $-21.00 | $-25.00 | $-25.00 |
| Surprise | -604.2% | +12.5% | -31.6% | -200.0% |
| Revenue | ||||
| Estimate | $1.5M | $1.4M | $6.8M | $13.7M |
| Actual | $108000 | $73000 | $60000 | $77000 |
| Surprise | -92.6% | -94.8% | -99.1% | -99.4% |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Sep 30, 2026 | $-1.69 | $-0.24 | -604.2 % |
| Q1 | May 29, 2026 | $-21.00 | $-24.00 | 12.5 % |
| Q4 | Mar 26, 2026 | $-25.00 | $-19.00 | -31.6 % |
| Q3 | Nov 26, 2025 | $-25.00 | $25.00 | -200.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Sep 30, 2026 | $108.00K | $1.47M | -92.6 % |
| Q1 | May 29, 2026 | $73.00K | $1.40M | -94.8 % |
| Q4 | Mar 26, 2026 | $60.00K | $6.77M | -99.1 % |
| Q3 | Nov 26, 2025 | $77.00K | $13.73M | -99.4 % |